methyl 5-aminolevulinate has been researched along with calcitriol in 7 studies
| Studies (methyl 5-aminolevulinate) | Trials (methyl 5-aminolevulinate) | Recent Studies (post-2010) (methyl 5-aminolevulinate) | Studies (calcitriol) | Trials (calcitriol) | Recent Studies (post-2010) (calcitriol) |
|---|---|---|---|---|---|
| 524 | 152 | 319 | 16,107 | 1,224 | 3,710 |
| Protein | Taxonomy | methyl 5-aminolevulinate (IC50) | calcitriol (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0093 | |
| Vitamin D3 receptor | Homo sapiens (human) | 0.3401 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.0093 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cicarma, E; Juzeniene, A; Ma, LW; Moan, J; Tuorkey, M | 1 |
| Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K; Wulf, HC | 1 |
| Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K | 1 |
| Nissen, CV; Philipsen, PA; Wiegell, SR; Wulf, HC | 1 |
| Galimberti, GN | 1 |
| Festa-Neto, C; Grinblat, B; Haedersdal, M; Szeimies, RM; Torezan, L; Valente, N | 1 |
| Festa-Neto, C; Grinblat, B; Haedersdal, M; Szeimies, RM; Torezan, L | 1 |
3 trial(s) available for methyl 5-aminolevulinate and calcitriol
| Article | Year |
|---|---|
Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: A case series.
Topics: Adult; Aged; Aminolevulinic Acid; Calcitriol; Dermatologic Agents; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Remission Induction; Scalp; Sunlight | 2018 |
A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Skin; Treatment Outcome | 2018 |
A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Calcitriol; Dermatologic Agents; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses | 2021 |
4 other study(ies) available for methyl 5-aminolevulinate and calcitriol
| Article | Year |
|---|---|
Calcitriol treatment improves methyl aminolaevulinate-based photodynamic therapy in human squamous cell carcinoma A431 cells.
Topics: Aminolevulinic Acid; Calcitriol; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Tumor Stem Cell Assay | 2009 |
Calcipotriol pretreatment enhances methyl aminolevulinate-induced protoporphyrin IX: an in vivo study in hairless mice.
Topics: Aminolevulinic Acid; Animals; Calcitriol; Dermatologic Agents; Female; Mice; Mice, Nude; Photosensitizing Agents; Protoporphyrins; Skin | 2015 |
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays | 2016 |
Short-term chemical pretreatment cannot replace curettage in photodynamic therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Curettage; Dermatologic Agents; Drug Therapy, Combination; Female; Fluorescence; Healthy Volunteers; Humans; Keratolytic Agents; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Salicylic Acid; Young Adult | 2016 |